Table 1. Comparison of subjects with and without hypnotic use*.
Characteristic | Hypnotic Users (N = 5693) | Hypnotic Nonusers(N = 28,465) | P Value+ | ||
Age, median (IQR), y | 65 | (57–74) | 65 | (57–74) | 1.000 |
50–65 | 2785 | (48.9%) | 13,925 | (48.9%) | |
>65 | 2908 | (51.1%) | 14,540 | (51.1%) | |
Sex | 1.000 | ||||
Male | 2520 | (44.3%) | 12,600 | (44.3%) | |
Female | 3173 | (55.7%) | 15,865 | (55.7%) | |
Comorbidities | |||||
Hypertension | 3163 | (55.6%) | 10,483 | (36.8%) | <.001 |
Diabetes | 1456 | (25.6%) | 4904 | (17.2%) | <.001 |
Hyperlipidemia | 1907 | (33.5%) | 6092 | (21.4%) | <.001 |
Stroke | 1161 | (20.4%) | 3522 | (12.4%) | <.001 |
Abbreviation: IQR, interquartile range.
Data are number (percentage) except where indicated.
+Group comparisons by the chi-square test.